• vaccine4.jpg

    $2bn global coronavirus vaccine fund announced at Gavi summit

    5 Jun, 2020

    A $2bn procurement fund aimed at ensuring that poorer countries can access doses of a potential coronavirus vaccine has been announced at a virtual summit hosted by the UK.



    The announcement was made at the third Gavi vaccine alliance replenishment summit, a virtual pledging event that separately raised $8.8bn, above the target of $7.4bn, for the private-public alliance’s general work on immunising millions of people worldwide from longstanding diseases such as measles.
    <...
  • vaxin.jpg

    Fauci says he's optimistic about coronavirus vaccine protection, but concerned about how long that protection will last

    4 Jun, 2020

    The USA's leading infectious disease expert Dr. Anthony Fauci said he’s “cautiously optimistic” a coronavirus vaccine will provide some protection against SARS-CoV-2 and COVID-19, the illness it causes, but is concerned about how long that protection could last.

    In an interview with JAMA editor-in-chief Howard Bauchner Tuesday, the director of the National Institute of Allergy and Infectious Diseases questioned the "durability" of candidate vaccines.

    Click here for refe...
  • vaccine3.jpg

    In-home antibody test shows promise; recovering surgery patients at risk from coronavirus

    2 Jun, 2020
    The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

    In-home COVID-19 antibody test shows high accuracy

    Recovering surgery patients at risk from coronavirus

    Immune system overreaction may not be cause of bad outcomes

    COVID-19 survivors will need rehab therapy, experts say


    Click here for reference



  • trace.jpg

    Effective test, track and tracing 'can reduce lost working hours by 50%'

    29 May, 2020

    An effective track-and-trace system to prevent a second coronavirus peak will not only save lives, it could reduce the number of working hours lost to illness by as much as 50%, according to a major global study.

    The International Labour Organisation said the effective testing and tracing of infections was essential if employers wanted staff to return to work and for them to stay healthy.


    Click here for reference







  • genom.jpg

    How countries are using genomics to help avoid a second coronavirus wave

    28 May, 2020

    As many countries emerge from lockdowns, researchers are poised to use genome sequencing to avoid an expected second wave of COVID-19 infections.

    Since the first whole-genome sequence of the new coronavirus, SARS-CoV-2, was shared online on 11 January, scientists have sequenced and shared some 32,000 viral genomes from around the world. Such a vast amount of data has allowed researchers to trace the origin of COVID-19 outbreaks in their countries and pinpoint when communi...
  • remesdivir.jpg

    Coronavirus: UK authorises anti-viral drug remdesivir

    27 May, 2020

    A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is being made available on the NHS. Health Secretary Matt Hancock said it was probably the biggest step forward in the treatment of coronavirus since the crisis began. Remdesivir is an anti-viral medicine that has been used against Ebola.

    Click here for reference








  • sk_covid_2.jpg

    Leveraging South Korea's Covid-19 success

    26 May, 2020

    South Koreans from all walks of lives are experiencing a strong sense of déjà vu as the Covid-19 pandemic has miraculously turned their country into the poster child for how to manage a public health crisis. The so-called "K-quarantine" and "K-testing", which have been duplicated worldwide, have added an extra layer to the existing Hallyu or "Korean Wave" of virtuosity and respectability, as the nation's actions have protected and saved lives even though the government is still fighting a...
  • Captura_de_pantalla_2020-05-25_a_las_8_53_29.png

    Coronavirus cases, hospitalizations and ICU admissions in Spain at lowest level since March

    25 May, 2020

    The daily data covering the coronavirus epidemic in Spain continued in the same direction on Sunday, according to the latest figures supplied by the Health Ministry. Once again, the majority of indicators were at low levels, while there were continuing problems with the notification of the figures from the Catalonia region.

    New infections came in at 246, hospitalizations at 86, and new intensive care unit (ICU) admissions were at three – all of which were the lowest seen since Marc...
  • _112289208_gettyimages-1212156018-1.jpg

    Hydroxychloroquine trial begins in the UK

    22 May, 2020

    A trial to see whether two anti-malarial drugs could prevent Covid-19 has begun in Brighton and Oxford.

    Chloroquine, hydroxychloroquine or a placebo will be given to more than 40,000 healthcare workers from Europe, Africa, Asia and South America.

    All the participants are staff who are in contact with Covid-19 patients.

    Click here for reference








  • WHO.png

    WHO assembly passes a resolution to investigate global pandemic response

    20 May, 2020

    Member states have backed a resolution strongly supportive of the World Health Organization, after Donald Trump issued a fresh broadside against the UN body, giving it 30 days to make unspecified reforms or lose out on US funding. None of the WHO's 194 members states raised objections to the resolution brought by the EU on behalf of more than 100 countries. The resolution backs the WHO’s leadership and said there needed to be an investigation into the global response to the coronavir...
  • foto_0000000420200518101813.jpg

    Coronavirus vaccine from Moderna appears safe, shows promise in data from eight people

    19 May, 2020

    Moderna Inc’s (MRNA.O) experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday.


    The data comes from eight people who took part in a 45-subject safety trial that kicked off in March. The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more tha...
  • Captura_de_pantalla_2020-05-17_a_las_23_47_16.png

    Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

    17 May, 2020
    Abstract"A novel coronavirus was recently discovered and termed SARS-CoV-2. Human infection can cause coronavirus disease 2019 (COVID-19), which has been rapidly spreading around the globe. SARS-CoV-2 shows some similarities to other coronaviruses. However, treatment options and a cellular understanding of SARS-CoV-2 infection are lacking. Here we identify the host cell pathways modulated by SARS-CoV-2 infection and show that inhibition of these pathways prevent viral replication in human cel...